Medical device supplier Covidien Ltd. (COV), first discussed here on June 4, 2009 at a price of $35.65, continues to vector higher, taking out major, psychological resistance at $50 with ease.
Hence, if you haven’t already, it’s probably a good idea to to consider taking some profits off the table, if you’re in at/near $35.65 with COV. Even so, those investors who can tolerate the risk can maintain their full position and go for an even bigger gain, as COV will likely test $60 in 2011.
Read the complete article here.
Happy trading,
Curt
More on this topic
(What's this?)
(COV) Covidien’s Pipeline Device Cleared
(Stock Blog Hub, 4/13/11)
Premium: Healthcare Company with 40% Upside
(ValueWalk.com, 4/16/12)
Covidien to Buy SuperDimension for $300 Million
(Benzinga, 3/19/12)
(COV) Covidien plc Quarterly Earnings Top Expectations – Profits Skyrocket
(Stock Blog Hub, 11/12/10)

![[del.icio.us]](http://pennystockdd.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://pennystockdd.com/wp-content/plugins/bookmarkify/digg.png)
![[Faves]](http://pennystockdd.com/wp-content/plugins/bookmarkify/faves.png)
![[LinkedIn]](http://pennystockdd.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://pennystockdd.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://pennystockdd.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Technorati]](http://pennystockdd.com/wp-content/plugins/bookmarkify/technorati.png)




